Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Applied Research in Antimicrobial Resistance: Studies of Susceptibility Testing on Gram-negative Multidrug Resistant Organisms, Funding Opportunity Announcement (FOA) CI07-003, 30384-30385 [E7-10422]
Download as PDF
<![CDATA[
30384
Federal Register / Vol. 72, No. 104 / Thursday, May 31, 2007 / Notices
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for ‘‘Ambulatory Safety and
Quality Program: Improving Quality
through Clinician Use of Health IT
(R18),’’ are to be reviewed and
discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: Ambulatory Safety and
Quality Program: Improving Quality through
Clinician Use of Health IT (R18).
Date: July 10–12, 2007 (Open on July 11
from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting).
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, Maryland 20878.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priority dictate.
Dated: May 22, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–2688 Filed 5–30–07; 8:45 am]
sroberts on PROD1PC70 with NOTICES
Agency for Healthcare Research and
Quality Contract Review Meeting
In accordance with section 10(a) of
the Federal Advisory Committee Act as
amended (5 U.S.C., Appendix 2),
announcement is made of an Agency for
Healthcare Research and Quality
(AHRQ) Technical Review Committee
(TRC) meeting. This TRC’s charge is to
provide, on behalf of AHRQ, review of
contract proposals and
recommendations to the Director,
AHRQ, regarding the technical merit of
proposals submitted in response to a
Jkt 211001
Dated: May 22, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–2681 Filed 5–25–07; 10:42 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Occupational Health
and Safety Research Member Conflict,
Program Announcement (PA) 04–038
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
16:01 May 30, 2007
Name of TRC: The Agency for HealthCare
Research and Quality, ‘‘Evidence-based
Practice Centers’’.
Date: June 11–12, 2007.
Place: Agency for HealthCare Research and
Quality, 540 Gaither Road, Conference
Center, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain
information regarding this meeting should
contact Beth Collins-Sharp, Center for
Outcomes and Evidence, 540 Gaither Road,
Rockville, Maryland 20850, (301) 427–1503.
Centers for Disease Control and
Prevention
BILLING CODE 4160–90–M
VerDate Aug<31>2005
Request for Proposals (RFPs) regarding
‘‘Evidence-based Practice Centers’’,
issued on March 8, 2007.
The upcoming TRC meeting will be
closed to the public in accordance with
the Federal Advisory Committee Act
(FACA), section 10(d) of 5 U.S.C.,
Appendix 2, implementing regulations,
and procurement regulations, 41 CFR
101–6.1023 and 48 CFR section
315.604(d). The discussions at this
meeting of contract proposals submitted
in response to the above-referenced RFP
are likely to reveal proprietary and
personal information concerning
individuals associated with the
proposals. Such information is exempt
from disclosure under the above-cited
FACA provision that protects the free
exchange of candid views, and under
the procurement rules that prevent
undue interference with Committee and
Department operations.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Time and Date: 1 p.m.–4 p.m., July 12,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of research grant applications in
response to ‘‘Occupational Health and Safety
Research Member Conflict,’’ PA 04–038.
Contact Person for More Information:
George Bockosh, Scientific Review
Administrator, 625 Cochrans Mill Road,
Mailstop P–05, Pittsburgh, PA 15222,
telephone (412) 386–6465.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 24, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–10421 Filed 5–30–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Applied Research in
Antimicrobial Resistance: Studies of
Susceptibility Testing on Gramnegative Multidrug Resistant
Organisms, Funding Opportunity
Announcement (FOA) CI07–003
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Time and Date: 12 p.m.–4 p.m., June 28,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of research grant applications in
response to FOA CI07–003, ‘‘Applied
Research in Antimicrobial Resistance:
Studies of Susceptibility Testing on Gramnegative Multidrug Resistant Organisms.’’
Contact Person for More Information:
Trudy Messmer, PhD, Scientific Review
Administrator, 1600 Clifton Road, Mailstop
C–19, Atlanta, GA 30333, telephone (404)
639–2176.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
E:\FR\FM\31MYN1.SGM
31MYN1
Federal Register / Vol. 72, No. 104 / Thursday, May 31, 2007 / Notices
30385
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 24, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–10422 Filed 5–30–07; 8:45 am]
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Racial and Ethnic
Approaches to Community Health
Across the United States (REACH US),
Request for Applications (RFA) DP07–
707
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Improving Public
Health Practice Through Translation
Research, Request for Applications
(RFA) CD07–005
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Travelers’ Health
Research Centers—Evaluation of
Measures To Protect the Health of
International Travelers, Funding
Opportunity Announcement (FOA)
CI07–002
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
sroberts on PROD1PC70 with NOTICES
Time and Date:
12 p.m.–4 p.m., June 29, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of research grant applications in
response to FOA CI07–002, ‘‘Travelers’’
Health Research Centers—Evaluation of
Measures To Protect the Health of
International Travelers.’’
Contact Person for More Information:
Trudy Messmer, PhD, Scientific Review
Administrator, 1600 Clifton Road, Mailstop
C–19, Atlanta, GA 30333, telephone (404)
639–2176.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 24, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–10433 Filed 5–30–07; 8:45 am]
Times and Dates:
8 a.m.–5 p.m., June 18, 2007 (Closed).
8 a.m.–5 p.m., June 19, 2007 (Closed).
8 a.m.–5 p.m., June 20, 2007 (Closed).
8 a.m.–5 p.m., June 21, 2007 (Closed).
8 a.m.–5 p.m., June 22, 2007 (Closed).
Place: Atlanta Marriott Century Center
Hotel, 2000 Century Boulevard, NE., Atlanta,
GA 30345, Telephone (404) 325–0000.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of research grant applications in
response to RFA DP07–707, ‘‘Racial and
Ethnic Approaches to Community Health
Across the United States (REACH US).’’
Contact Person for More Information:
Thijuanie Lockhart, Program & Management
Analyst, CDC, 4770 Buford Highway, NE.,
Mail Stop K–30, Atlanta, GA 30341,
Telephone (404) 488–5303.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 24, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–10434 Filed 5–30–07; 8:45 am]
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Times and Dates: 9 a.m.–5 p.m., June 25,
2007 (Closed). 9 a.m.–5 p.m., June 26, 2007
(Closed).
Place: Doubletree Buckhead Hotel, 3342
Peachtree Road, N.E., Atlanta, GA 30326.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of the scientific merit of research
applications in response to RFA CD07–005,
‘‘Improving Public Health Practice Through
Translation Research.’’
Contact Person for More Information:
Christine J. Morrison, PhD, Scientific Review
Administrator, 1600 Clifton Road, NE.,
Mailstop D72, Atlanta, GA 30333, telephone
(404) 639–3098.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: May 24, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–10436 Filed 5–30–07; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
VerDate Aug<31>2005
16:01 May 30, 2007
Jkt 211001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\31MYN1.SGM
31MYN1
]]>Agencies
[Federal Register Volume 72, Number 104 (Thursday, May 31, 2007)]
[Notices]
[Pages 30384-30385]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-10422]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: Applied Research in Antimicrobial Resistance: Studies
of Susceptibility Testing on Gram-negative Multidrug Resistant
Organisms, Funding Opportunity Announcement (FOA) CI07-003
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting of the aforementioned Special
Emphasis Panel.
Time and Date: 12 p.m.-4 p.m., June 28, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of research grant applications in
response to FOA CI07-003, ``Applied Research in Antimicrobial
Resistance: Studies of Susceptibility Testing on Gram-negative
Multidrug Resistant Organisms.''
Contact Person for More Information: Trudy Messmer, PhD,
Scientific Review Administrator, 1600 Clifton Road, Mailstop C-19,
Atlanta, GA 30333, telephone (404) 639-2176.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and
[[Page 30385]]
other committee management activities, for both CDC and the Agency
for Toxic Substances and Disease Registry.
Dated: May 24, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-10422 Filed 5-30-07; 8:45 am]
BILLING CODE 4163-18-P
